Pigmented lesions, also known as melanocytic proliferations, are a type of skin disease. Brown, black, or blue pigmentation in a lesion indicates the presence of melanin, blood, or exogenous pigment. Discolored patches or growths on areas of skin that get direct sunlight are a common sign of skin cancer. Benign and malignant pigmented lesions are further subdivided into the subtypes of non-melanocytic and melanocytic lesions, respectively. Under the microscope, abnormal tissue is more probably cancerous, and this is what we mean when we talk about a malignant lesion. In this way, premalignant lesion excision decreases both the spread and incidence of malignant skin diseases. All forms of skin cancer are preventable if detected and treated early enough. Photodamage, or prolonged exposure to ultraviolet (UV) radiation, is a natural and environmental factor that contributes to the development of pigment lesions and other skin problems, including accelerated skin ageing.
Pigment lesions can affect people of almost any age. Pigmented lesions can be treated with numerous safe and cost-effective laser options, including the ErYAG and MedLite lasers.
Click Here to Request a sample copy @ https://www.coherentmarketinsights.com/insight/request-sample/1089
The market for pigmented lesion treatment is anticipated to expand as a result of rising demand for laser systems for the removal of pigmented lesions
In order to provide customers with cutting-edge options for the treatment of pigmented lesions, many companies are placing a strong emphasis on innovation. At the 23rd European Academy of Dermatology and Venereology (EADV) Congress in Amsterdam, for instance, Syneron Medical Ltd. introduced the PicoWay picosecond device for the treatment of pigmented lesions and the removal of tattoos. PicoWay is a device that can transmit signals at both 532nm and 1064nm wavelengths. In addition, the Lutronic XT Q-Switched, frequency doubled Nd:YAG laser, dubbed the Spectra XT, was released by Lutronic Corporation in 2014. This system has a wide range of treatment applications, such as those for pigmented lesion removal, melisma removal, tattoo removal, pore size reduction, and skin rejuvenation.
At the 2014 American Academy of Dermatology annual meeting, Cutera, Inc. debuted two novel laser systems. Hair removal, tattoo removal, and the elimination of benign pigmented lesions are the stated goals of both the excel HR and the Enlighten lasers. PicoSure, Cynosure’s tattoo- and pigment-removing energy delivery system, was granted FDA clearance in 2016.
Market for pigmented lesion treatment taxonomy
By Laser Type:
- Fractional CO2
- Infrared
- Diode
- Alexandrite
- Pulsed
- Potassium-Titanyl-Phosphate
- Nd:YAG
By Indication Type:
- Non-melanocytic lesions
- Inflammatory
- Benign neoplasms
- Hamartomas
- Malignant neoplasms
- Melanocytic lesions
- Malignant
- Benign
By End User
- Skin Clinics
- Hospitals
- Others
It is anticipated that the market for treating pigmented lesions will expand significantly in Asia Pacific during the forecast period
The worldwide market for pigmented lesion treatments can be broken down into the following regions: North America, Europe, Latin America, the Middle East, Asia-Pacific, and Africa. During the anticipated time period, North America is anticipated to hold the major share of the market, trailed by Europe and the Asia-Pacific region. Rising concerns about appearance and the rising incidence of pigmented lesions are fueling the expansion of the market for pigmented lesion treatment in North America. Market growth for pigmented lesion treatments in North America is supported by the fact that each year more than 5.4 Mn cases of non-melanoma skin cancer are reported in the United States and more than 3.3 Mn people receive treatment. The market for removing pigmented lesions is projected to expand rapidly in the Asia-Pacific region due to factors such as growing government funding for lesion removal. This year, CeBIT Australia featured 12 cutting-edge technology startups chosen by the New South Wales (NSW) Government. Dermaspec is one such company that offers a high-quality, color adjusted low-cost camera for dermatoscopic imaging of pigmented skin lesions. at a reasonable price point, which in turn will support the expansion of the pigmented lesion market in the Asia-Pacific region.
In 2016, product revenue for Syneron Medicals Ltd. increased roughly 20% Y-o-Y in North America, roughly 25% Y-o-Y in Asia-Pacific, and roughly 9% Y-o-Y in EMEA. This growth in Asia-Pacific is supported by the company’s revenue in these regions.
Inventions in treatment systems, spurred by rising product competition, are expected to fuel expansion of the global market for pigmented lesion treatment
In September 2017, Fotona, a company with offices in the United States and Europe, received FDA clearance for the StarWalker MaQX Q-Switched laser system, which can be used to treat tattoos, pigmented and vascular lesions, acne and scar revision, and permanent hair reduction. The competition between established businesses in the market for pigmented lesion treatment is bound to increase as new products are continually approved.
Some of the most important companies in the world market for pigmented lesion treatment are Lutronic Corporation, Fotona d.d., Alma Lasers, Ltd., EL.En. S.p.A., Solta Medical Inc., Cynosure, Inc., Syneron Medical Ltd., Sciton, Inc., Cutera Inc., Lumenis Ltd., Strata Skin Sciences, Inc., and Lynton Lasers Ltd.
Buy-Now this Premium Report @ https://www.coherentmarketinsights.com/insight/buy-now/1089
Reason to Buy this Report:
■ Analysis of the impact of technological advancements on the market and the emerging trends shaping the industry in the coming years.
■ Examination of the regulatory and policy changes affecting the market and the implications of these changes for market participants.
■ Overview of the competitive landscape in the Pigmented Lesion Treatment market, including profiles of the key players, their market share, and strategies for growth.
■ Identification of the major challenges facing the market, such as supply chain disruptions, environmental concerns, and changing consumer preferences, and analysis of how these challenges will affect market growth.
■ Evaluation of the potential of new products and applications in the market, and analysis of the investment opportunities for market participants.
Table of Contents with Major Points:
Executive Summary
- Introduction
- Key Findings
- Recommendations
- Definitions and Assumptions
Executive Summary
Market Overview
- Definition of Pigmented Lesion Treatment Market
- Market Dynamics
- Drivers
- Restraints
- Opportunities
- Trends and Developments
Key Insights
- Key Emerging Trends
- Key Developments Mergers and Acquisition
- New Product Launches and Collaboration
- Partnership and Joint Venture
- Latest Technological Advancements
- Insights on Regulatory Scenario
- Porters Five Forces Analysis
Qualitative Insights Impact of COVID-19 on Global Pigmented Lesion Treatment Market
- Supply Chain Challenges
- Steps taken by Government/Companies to overcome this impact
- Potential opportunities due to COVID-19 outbreak
Conclusion
Appendix
- Data Sources
- Abbreviations
- Disclaimer
TOC Continued…!
Ask Here for Customization Report @ https://www.coherentmarketinsights.com/insight/request-customization/1089
Explore More Report:
Drug device combination products market
Us uterine fibroid treatment market
Radio frequency beauty equipment market
Neonatal infant care equipment market
Wound debridement products market
Middle east and asia injectable drugs market
Neuromodulation devices market
𝐀𝐛𝐨𝐮𝐭 𝐔𝐬:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having sales office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 57 countries worldwide. We create value for clients through our highly reliable and accurate reports. We are also committed in playing a leading role in offering insights in various sectors post-COVID-19 and continue to deliver measurable, sustainable results for our clients.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: +1-206-701-6702
UK: +44-020-8133-4027
Japan: +81-050-5539-1737
India: +91-848-285-0837
Email: sales@coherentmarketinsights.com